-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
Characteristics of diabetic ketoacidosis in adult patients in Bahrain
Husain Taha Radhi*, Maryam Abdalla El-Amin*, Aysha Asif Sarwani*, Fatema Husain Mandeel*
Research Article: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
The evolving field of post-transplant therapy in multiple myeloma
Sarah A Holstein, & Philip L McCarthy
Clinical Trail Outcomes: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
New treatment option for delivering anticancer drugs demonstrated in clinical trial
News and Views: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Neoadjuvant chemotherapy in bladder cancer
Christopher M Tully, Gopa Iyer, Dean F Bajorin
Review: Clinical Trail Outcomes: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
The trials of antiepileptic drug trials
Timothy E Welty
Editorial: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clinical Investigation (2011) 1(5) 719-724.
Editor\\\'s Note: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Sumathi Nambiar
Sumathi Nambiar
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Sumathi Nambiar
Sumathi Nambiar
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Sumathi Nambiar
Sumathi Nambiar
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Sumathi Nambiar
Sumathi Nambiar
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Sumathi Nambiar
Sumathi Nambiar
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Sumathi Nambiar
Sumathi Nambiar
Interview: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation